Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,588.80
(
-0.87%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
107.55
(
0.91%
)
Bitcoin
69,287.66
(
-2.74%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 90193

Friday, 02/05/2010 11:28:18 AM

Friday, February 05, 2010 11:28:18 AM

Post# of 257257
VRTX:

A question on the call just asked about dosing 950 for more then 12 weeks (with 222) and they implied its not going to happen.

That was a good question—glad someone asked it. Telaprevir gets rid of wild-type virus really fast, so extending the duration of Telaprevir beyond 12 weeks does more harm than good. The question is what the VX-222-based regimen will consist of after 12 weeks, and the answer is evidently not yet known.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now